Happy to report that our Young Investigator Award, "Metabolic reprogramming of tumor-specific T cells for immunotherapy," was funded through the Alliance for Cancer Gene Therapy! This award supports research using genetic engineering to create superior, long-lived T cell for the treatment of murine cancer, and using that model to generate superior human T cells!
Greg talks at a camera in his office for 2 minutes!
As part of the UPCI Video Blog Feature, Greg discussed the latest findings of our Immunity paper! Check it out!
Delgoffe Lab featured in SU2C Innovative Research Grant video
Thanks to the Stand Up To Cancer Innovative Research Program, we received funding to explore metabolic reprogramming using some really cutting-edge therapeutic tools: oncolytic viruses. While this was a pretty stressful grant process, we are thrilled to be a part of the SU2C team.